ADAM Bisaga
Affiliations: | Columbia University, New York, NY |
Area:
addiction, pharmacotherapyGoogle:
"ADAM Bisaga"Mean distance: 53433
Parents
Sign in to add mentor| Herbert D. Kleber | research scientist | 1997- | Columbia University Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tardelli V, Xu KY, Bisaga A, et al. (2023) Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. Bmj Mental Health. 26 |
| Greiner MG, Shulman M, Opara O, et al. (2023) Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study. Contemporary Clinical Trials. 128: 107148 |
| Williams AR, Aronowitz S, Gallagher R, et al. (2022) A Virtual-First Telehealth Treatment Model for Opioid Use Disorder. Journal of General Internal Medicine |
| Shulman M, Hu MC, Sullivan MA, et al. (2022) Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials. Drug and Alcohol Dependence. 233: 109343 |
| Levine A, Clemenza K, Weiss S, et al. (2021) Discovering Non-Invasive Biomarkers Predictive of Opioid Use Disorder Treatment Response. Cns Spectrums. 26: 173 |
| Levin FR, Mariani JJ, Pavlicova M, et al. (2021) Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial. Drug and Alcohol Dependence. 219: 108482 |
| Kidd JD, Smith JL, Hu MC, et al. (2020) Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum. Advances in Medical Education and Practice. 11: 455-461 |
| Tardelli VS, Bisaga A, Arcadepani FB, et al. (2020) Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology |
| Nunes EV, Bisaga A, Krupitsky E, et al. (2020) Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246. Addiction (Abingdon, England) |
| Ghosh A, Roub F, Bisaga A. (2020) Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD). Journal of Psychosomatic Research. 135: 110159 |